ArticleOncotarget2017
Preclinical study of CC223 as a potential anti-ovarian cancer agent.
Zhenzhen Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleOncotarget2017
Zhenzhen Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.